Skip to main content

Obesity and the Growth Hormone Axis

  • Chapter
  • First Online:

Abstract

Growth hormone (GH), as its name implies, promotes growth and alters nutrient metabolism through direct activation of the GH receptor (GHR) on target tissues. GH also indirectly regulates growth and nutrient metabolism by altering production of additional factors. One of the most important secondary effects of GH action is insulin-like growth factor-1 (IGF-1). Many of the growth-promoting activities that result from GH occur via GH-stimulated IGF-1 production. Due to the strong link between GH and IGF-1, they are often referred to collectively as the GH/IGF-1 axis. The GH/IGF-1 axis has anabolic effects on most tissues, including the heart, liver, kidneys, and intestines; however, GH – but not IGF-1 – has a dramatic catabolic effect on adipose tissue (AT). This chapter will focus mainly on GH, describe the clinical conditions and mouse lines with alterations in this axis along with their adiposity phenotype, and conclude by considering the role and therapeutic use of GH in obesity.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Abrahamsen, B., Nielsen, T. L., Hangaard, J., Gregersen, G., Vahl, N., Korsholm, L., Hansen, T. B., Andersen, M., & Hagen, C. (2004). Dose-, IGF-I- and sex-dependent changes in lipid profile and body composition during GH replacement therapy in adult onset GH deficiency. European Journal of Endocrinology, 150(5), 671–679.

    Article  PubMed  CAS  Google Scholar 

  • Abreu, A., Tovar, A. P., Castellanos, R., Valenzuela, A., Giraldo, C. M., Pinedo, A. C., Guerrero, D. P., Barrera, C. A., Franco, H. I., Ribeiro-Oliveira, A., Jr., Vilar, L., Jallad, R. S., Duarte, F. G., Gadelha, M., Boguszewski, C. L., Abucham, J., Naves, L. A., Musolino, N. R., de Faria, M. E., Rossato, C., & Bronstein, M. D. (2016). Challenges in the diagnosis and management of acromegaly: A focus on comorbidities. Pituitary, 19(4), 448–457. https://doi.org/10.1007/s11102-016-0725-2.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Agladioglu, S. Y., Cetinkaya, S., Savas Erdeve, S., Onder, A., Kendirci, H. N., Bas, V. N., & Aycan, Z. (2013). Diabetes mellitus with Laron syndrome: case report. Journal of Pediatric Endocrinology & Metabolism: JPEM, 26(9–10), 955–958. https://doi.org/10.1515/jpem-2012-0411.

    Article  Google Scholar 

  • Ahn, C. W., Kim, C. S., Nam, J. H., Kim, H. J., Nam, J. S., Park, J. S., Kang, E. S., Cha, B. S., Lim, S. K., Kim, K. R., Lee, H. C., & Huh, K. B. (2006). Effects of growth hormone on insulin resistance and atherosclerotic risk factors in obese type 2 diabetic patients with poor glycaemic control. Clinical Endocrinology, 64(4), 444–449.

    PubMed  CAS  Google Scholar 

  • Alatzoglou, K. S., Webb, E. A., Le Tissier, P., & Dattani, M. T. (2014). Isolated growth hormone deficiency (GHD) in childhood and adolescence: Recent advances. Endocrine Reviews, 35(3), 376–432. https://doi.org/10.1210/er.2013-1067.

    Article  PubMed  CAS  Google Scholar 

  • Alderman, J. M., Flurkey, K., Brooks, N. L., Naik, S. B., Gutierrez, J. M., Srinivas, U., Ziara, K. B., Jing, L., Boysen, G., Bronson, R., Klebanov, S., Chen, X., Swenberg, J. A., Stridsberg, M., Parker, C. E., Harrison, D. E., & Combs, T. P. (2009). Neuroendocrine inhibition of glucose production and resistance to cancer in dwarf mice. Experimental Gerontology, 44(1–2), 26–33.

    Article  PubMed  CAS  Google Scholar 

  • Andersen B, Pearse RV 2nd, Jenne K, Sornson M, Lin SC, Bartke A, Rosenfeld MG (1995) The Ames dwarf gene is required for Pit-1 gene activation. Developmental Biology 172 (2):495–503.

    Article  PubMed  CAS  Google Scholar 

  • Arai, Y., Takayama, M., Abe, Y., & Hirose, N. (2011). Adipokines and aging. Journal of Atherosclerosis and Thrombosis, 18(7), 545–550. doi:JST.JSTAGE/jat/7039 [pii].

    Article  PubMed  CAS  Google Scholar 

  • Asayama, K., Amemiya, S., Kusano, S., & Kato, K. (1984). Growth-hormone-induced changes in postheparin plasma lipoprotein lipase and hepatic triglyceride lipase activities. Metabolism, 33(2), 129–131.

    Article  PubMed  CAS  Google Scholar 

  • Bartke, A. (2003). Can growth hormone (GH) accelerate aging? Evidence from GH-transgenic mice. Neuroendocrinology, 78(4), 210–216.

    Article  PubMed  CAS  Google Scholar 

  • Bartke, A. (2008). Impact of reduced insulin-like growth factor-1/insulin signaling on aging in mammals: Novel findings. Aging Cell, 7(3), 285–290.

    Article  PubMed  CAS  Google Scholar 

  • Bartke, A., & Westbrook, R. (2012). Metabolic characteristics of long-lived mice. Frontiers in Genetics, 3, 288. https://doi.org/10.3389/fgene.2012.00288.

    Article  PubMed  PubMed Central  Google Scholar 

  • Bastie, C. C., Nahle, Z., McLoughlin, T., Esser, K., Zhang, W., Unterman, T., & Abumrad, N. A. (2005). FoxO1 stimulates fatty acid uptake and oxidation in muscle cells through CD36-dependent and -independent mechanisms. The Journal of Biological Chemistry, 280(14), 14222–14229. https://doi.org/10.1074/jbc.M413625200.

    Article  PubMed  CAS  Google Scholar 

  • Beck, J. C., McGarry, E. E., Dyrenfurth, I., & Venning, E. H. (1957). Metabolic effects of human and monkey growth hormone in man. Science, 125, 884.

    Article  PubMed  CAS  Google Scholar 

  • Benencia, F., Harshman, S., Duran-Ortiz, S., Lubbers, E. R., List, E. O., Householder, L., Alnaeeli, M., Liang, X., Welch, L., Kopchick, J. J., & Berryman, D. E. (2014). Male bovine GH transgenic mice have decreased adiposity with an adipose depot-specific increase in immune cell populations. Endocrinology:en20141794. https://doi.org/10.1210/en.2014-1794.

  • Bengtsson, B. A., Brummer, R. J., Eden, S., & Bosaeus, I. (1989). Body composition in acromegaly. Clinical Endocrinology, 30(2), 121–130.

    Article  PubMed  CAS  Google Scholar 

  • Bengtsson B. A., Edén S., Lönn L., Kvist H., Stokland A., Lindstedt G., Bosaeus I., Tölli J., Sjöström L., & Isaksson O.G. (1993). Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. The Journal of Clinical Endocrinology & Metabolism, 76(2), 309–317.

    CAS  Google Scholar 

  • Berryman, D., Householder, L., Lesende, V., List, E., & Kopchick, J. J. (2015). Living large: What mouse models reveal about growth hormone. In N. A. Berger (Ed.), Murine models, energy, balance, and Cancer (pp. 65–95). New York: Springer.

    Chapter  Google Scholar 

  • Berryman, D. E., Glad, C. A., List, E. O., & Johannsson, G. (2013). The GH/IGF-1 axis in obesity: Pathophysiology and therapeutic considerations. Nature Reviews. Endocrinology, 9(6), 346–356. https://doi.org/10.1038/nrendo.2013.64. nrendo.2013.64 [pii].

    Article  PubMed  CAS  Google Scholar 

  • Berryman, D. E., List, E. O., Coschigano, K. T., Behar, K., Kim, J. K., & Kopchick, J. J. (2004). Comparing adiposity profiles in three mouse models with altered GH signaling. Growth Hormone & IGF Research, 14(4), 309–318.

    Article  CAS  Google Scholar 

  • Berryman, D. E., List, E. O., Kohn, D. T., Coschigano, K. T., Seeley, R. J., & Kopchick, J. J. (2006). Effect of growth hormone on susceptibility to diet-induced obesity. Endocrinology, 147(6), 2801–2808. doi:en.2006-0086 [pii]. https://doi.org/10.1210/en.2006-0086.

    Article  PubMed  CAS  Google Scholar 

  • Berryman, D. E., List, E. O., Palmer, A. J., Chung, M. Y., Wright-Piekarski, J., Lubbers, E., O’Connor, P., Okada, S., & Kopchick, J. J. (2010). Two-year body composition analyses of long-lived GHR null mice. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 65(1), 31–40.

    Article  PubMed  CAS  Google Scholar 

  • Berryman, D. E., List, E. O., Sackmann-Sala, L., Lubbers, E., Munn, R., & Kopchick, J. J. (2011). Growth hormone and adipose tissue: Beyond the adipocyte. Growth Hormone & IGF Research, 21(3), 113–123. https://doi.org/10.1016/j.ghir.2011.03.002. S1096-6374(11)00018-9 [pii].

    Article  CAS  Google Scholar 

  • Berryman, D. E., Lubbers, E. R., Magon, V., List, E. O., & Kopchick, J. J. (2014). A dwarf mouse model with decreased GH/IGF-1 activity that does not experience life-span extension: Potential impact of increased adiposity, leptin, and insulin with advancing age. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 69(2), 131–141. https://doi.org/10.1093/gerona/glt069. glt069 [pii].

    Article  PubMed  CAS  Google Scholar 

  • Bonkowski, M. S., Rocha, J. S., Masternak, M. M., Al Regaiey, K. A., & Bartke, A. (2006). Targeted disruption of growth hormone receptor interferes with the beneficial actions of calorie restriction. Proceedings of the National Academy of Sciences of the United States of America, 103(20), 7901–7905.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Boot, A. M., Engels, M. A., Boerma, G. J., Krenning, E. P., & De Muinck Keizer-Schrama, S. M. (1997). Changes in bone mineral density, body composition, and lipid metabolism during growth hormone (GH) treatment in children with GH deficiency. The Journal of Clinical Endocrinology and Metabolism, 82(8), 2423–2428. https://doi.org/10.1210/jcem.82.8.4149.

    Article  PubMed  CAS  Google Scholar 

  • Boucher, J., Softic, S., El Ouaamari, A., Krumpoch, M. T., Kleinridders, A., Kulkarni, R. N., O’Neill, B. T., & Kahn, C. R. (2016). Differential roles of insulin and IGF-1 receptors in adipose tissue development and function. Diabetes, 65(8), 2201–2213. https://doi.org/10.2337/db16-0212.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Bredella, M. A., Lin, E., Brick, D. J., Gerweck, A. V., Harrington, L. M., Torriani, M., Thomas, B. J., Schoenfeld, D. A., Breggia, A., Rosen, C. J., Hemphill, L. C., Wu, Z., Rifai, N., Utz, A. L., & Miller, K. K. (2012). Effects of GH in women with abdominal adiposity: A 6-month randomized, double-blind, placebo-controlled trial. European Journal of Endocrinology, 166(4), 601–611. https://doi.org/10.1530/EJE-11-1068. EJE-11-1068 [pii].

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Brooks, A. J., Dai, W., O’Mara, M. L., Abankwa, D., Chhabra, Y., Pelekanos, R. A., Gardon, O., Tunny, K. A., Blucher, K. M., Morton, C. J., Parker, M. W., Sierecki, E., Gambin, Y., Gomez, G. A., Alexandrov, K., Wilson, I. A., Doxastakis, M., Mark, A. E., & Waters, M. J. (2014). Mechanism of activation of protein kinase JAK2 by the growth hormone receptor. Science, 344(6185), 1249783. https://doi.org/10.1126/science.1249783. 1249783 [pii]. science.1249783 [pii].

    Article  PubMed  CAS  Google Scholar 

  • Brooks, N. L., Trent C. M., Raetzsch C. F., Flurkey K., Boysen G., et al. (2007). Low utilization of circulating glucose after food withdrawal in Snell dwarf mice. The Journal of Biological Chemistry, 282(48), 35069–35077.

    Article  PubMed  CAS  Google Scholar 

  • Brooks, A. J., & Waters, M. J. (2010). The growth hormone receptor: Mechanism of activation and clinical implications. Nature Reviews Endocrinology, 6(9), 515–525. https://doi.org/10.1038/nrendo.2010.123.

    Article  PubMed  CAS  Google Scholar 

  • Brown-Borg, H. M., Rakoczy, S. G., Sharma, S., & Bartke, A. (2009). Long-living growth hormone receptor knockout mice: Potential mechanisms of altered stress resistance. Experimental Gerontology, 44(1–2), 10–19.

    Article  PubMed  CAS  Google Scholar 

  • Brown, R. J., Adams, J. J., Pelekanos, R. A., Wan, Y., McKinstry, W. J., Palethorpe, K., Seeber, R. M., Monks, T. A., Eidne, K. A., Parker, M. W., & Waters, M. J. (2005). Model for growth hormone receptor activation based on subunit rotation within a receptor dimer. Nature Structural & Molecular Biology, 12(9), 814–821.

    Article  CAS  Google Scholar 

  • Chellakooty, M., Vangsgaard, K., Larsen, T., Scheike, T., Falck-Larsen, J., Legarth, J., Andersson, A. M., Main, K. M., Skakkebaek, N. E., & Juul, A. (2004). A longitudinal study of intrauterine growth and the placental growth hormone (GH)-insulin-like growth factor I axis in maternal circulation: Association between placental GH and fetal growth. The Journal of Clinical Endocrinology and Metabolism, 89(1), 384–391. https://doi.org/10.1210/jc.2003-030282.

    Article  PubMed  CAS  Google Scholar 

  • Chen, W. Y., Wight, D. C., Mehta, B. V., Wagner, T. E., & Kopchick, J. J. (1991). Glycine 119 of bovine growth hormone is critical for growth-promoting activity. Molecular Endocrinology, 5(12), 1845–1852.

    Article  PubMed  CAS  Google Scholar 

  • Chihara, K., Fujieda, K., Shimatsu, A., Miki, T., & Tachibana, K. (2010). Dose-dependent changes in body composition during growth hormone (GH) treatment in Japanese patients with adult GH deficiency: A randomized, placebo-controlled trial. Growth Hormone & IGF Research, 20(3), 205–211.

    Article  CAS  Google Scholar 

  • Christ, E. R., Cummings, M. H., Albany, E., Umpleby, A. M., Lumb, P. J., Wierzbicki, A. S., Naoumova, R. P., Boroujerdi, M. A., Sonksen, P. H., & Russell-Jones, D. L. (1999). Effects of growth hormone (GH) replacement therapy on very low density lipoprotein apolipoprotein B100 kinetics in patients with adult GH deficiency: A stable isotope study. The Journal of Clinical Endocrinology and Metabolism, 84(1), 307–316. https://doi.org/10.1210/jcem.84.1.5365.

    Article  PubMed  CAS  Google Scholar 

  • Ciresi, A., Amato, M. C., Pizzolanti, G., & Giordano, C. (2015). Serum visfatin levels in acromegaly: Correlation with disease activity and metabolic alterations. Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society, 25(5), 240–246. https://doi.org/10.1016/j.ghir.2015.07.002.

    Article  CAS  Google Scholar 

  • Ciresi, A., Pizzolanti, G., Leotta, M., Guarnotta, V., Teresi, G., & Giordano, C. (2016). Resistin, visfatin, leptin and omentin are differently related to hormonal and metabolic parameters in growth hormone-deficient children. Journal of Endocrinological Investigation. https://doi.org/10.1007/s40618-016-0475-z.

  • Clemmons, D. R., Snyder, D. K., Williams, R., & Underwood, L. E. (1987). Growth hormone administration conserves lean body mass during dietary restriction in obese subjects. The Journal of Clinical Endocrinology and Metabolism, 64(5), 878–883.

    Article  PubMed  CAS  Google Scholar 

  • Colao, A., Ferone, D., Marzullo, P., & Lombardi, G. (2004). Systemic complications of acromegaly: Epidemiology, pathogenesis, and management. Endocrine Reviews, 25(1), 102–152.

    Article  PubMed  CAS  Google Scholar 

  • Combs, T. P., Berg, A. H., Rajala, M. W., Klebanov, S., Iyengar, P., Jimenez-Chillaron, J. C., Patti, M. E., Klein, S. L., Weinstein, R. S., & Scherer, P. E. (2003). Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin. Diabetes, 52(2), 268–276.

    Article  PubMed  CAS  Google Scholar 

  • Cordoba-Chacon, J., Majumdar, N., List, E. O., Diaz-Ruiz, A., Frank, S. J., Manzano, A., Bartrons, R., Puchowicz, M., Kopchick, J. J., & Kineman, R. D. (2015). Growth hormone inhibits hepatic De novo Lipogenesis in adult mice. Diabetes, 64(9), 3093–3103. https://doi.org/10.2337/db15-0370.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Coschigano, K. T., Holland, A. N., Riders, M. E., List, E. O., Flyvbjerg, A., & Kopchick, J. J. (2003). Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin and IGF-1 levels and increased lifespan. Endocrinology, 144(9), 3799–3810.

    Article  PubMed  CAS  Google Scholar 

  • Cui, Y., Hosui, A., Sun, R., Shen, K., Gavrilova, O., Chen, W., Cam, M. C., Gao, B., Robinson, G. W., & Hennighausen, L. (2007). Loss of signal transducer and activator of transcription 5 leads to hepatosteatosis and impaired liver regeneration. Hepatology, 46(2), 504–513. https://doi.org/10.1002/hep.21713.

    Article  PubMed  CAS  Google Scholar 

  • De Boer, H., Blok, G. J., Voerman, H. J., De Vries, P. M., & van der Veen, E. A. (1992). Body composition in adult growth hormone-deficient men, assessed by anthropometry and bioimpedance analysis. The Journal of Clinical Endocrinology and Metabolism, 75(3), 833–837.

    PubMed  Google Scholar 

  • del Rincon, J. P., Iida, K., Gaylinn, B. D., McCurdy, C. E., Leitner, J. W., Barbour, L. A., Kopchick, J. J., Friedman, J. E., Draznin, B., & Thorner, M. O. (2007). Growth hormone regulation of p85alpha expression and phosphoinositide 3-kinase activity in adipose tissue: Mechanism for growth hormone-mediated insulin resistance. Diabetes, 56(6), 1638–1646. doi:db06-0299 [pii]. https://doi.org/10.2337/db06-0299.

    Article  PubMed  CAS  Google Scholar 

  • Diniz, R. D., Souza, R. M., Salvatori, R., Franca, A., Gomes-Santos, E., Ferrao TO, Oliveira, C. R., Santana, J. A., Pereira, F. A., Barbosa, R. A., Souza, A. H., Pereira, R. M., Oliveira-Santos, A. A., Silva, A. M., Santana-Junior, F. J., Valenca, E. H., Campos, V. C., & Aguiar-Oliveira, M. H. (2014). Liver status in congenital, untreated, isolated GH deficiency. Endocrine Connections, 3(3), 132–137. https://doi.org/10.1530/EC-14-0078.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • dos Santos, M. C., Nascimento, G. C., Nascimento, A. G., Carvalho, V. C., Lopes, M. H., Montenegro, R., Montenegro, R., Jr., Vilar, L., Albano, M. F., Alves, A. R., Parente, C. V., & dos Santos Faria, M. (2013). Thyroid cancer in patients with acromegaly: A case-control study. Pituitary, 16(1), 109–114. https://doi.org/10.1007/s11102-012-0383-y.

    Article  PubMed  Google Scholar 

  • Egecioglu, E., Bjursell, M., Ljungberg, A., Dickson, S. L., Kopchick, J. J., Bergstrom, G., Svensson, L., Oscarsson, J., Tornell, J., & Bohlooly, Y. M. (2006). Growth hormone receptor deficiency results in blunted ghrelin feeding response, obesity, and hypolipidemia in mice. American Journal of Physiology. Endocrinology and Metabolism, 290(2), E317–E325.

    Article  PubMed  CAS  Google Scholar 

  • Ehrenborg, E., & Krook, A. (2009). Regulation of skeletal muscle physiology and metabolism by peroxisome proliferator-activated receptor delta. Pharmacol Rev, 61(3), 373–393. https://doi.org/10.1124/pr.109.001560.

    Article  PubMed  CAS  Google Scholar 

  • Fan, Y., Fang, X., Tajima, A., Geng, X., Ranganathan, S., Dong, H., Trucco, M., & Sperling, M. A. (2014). Evolution of hepatic steatosis to fibrosis and adenoma formation in liver-specific growth hormone receptor knockout mice. Front Endocrinol (Lausanne), 5, 218. https://doi.org/10.3389/fendo.2014.00218.

    Article  Google Scholar 

  • Fan, Y., Menon, R. K., Cohen, P., Hwang, D., Clemens, T., DiGirolamo, D. J., Kopchick, J. J., Le Roith, D., Trucco, M., & Sperling, M. A. (2009a). Liver-specific deletion of the growth hormone receptor reveals essential role of growth hormone signaling in hepatic lipid metabolism. The Journal of Biological Chemistry, 284(30), 19937–19944. https://doi.org/10.1074/jbc.M109.014308.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Fathallah, N., Slim, R., Larif, S., Hmouda, H., & Ben Salem, C. (2015). Drug-induced Hyperglycaemia and diabetes. Drug Safety, 38(12), 1153–1168. https://doi.org/10.1007/s40264-015-0339-z.

    Article  PubMed  CAS  Google Scholar 

  • Fineberg, S. E., & Merimee, T. J. (1974). Acute metabolic effects of human growth hormone. Diabetes, 23(6), 499–504.

    Article  PubMed  CAS  Google Scholar 

  • Flint, D. J., Binart, N., Boumard, S., Kopchick, J. J., & Kelly, P. (2006). Developmental aspects of adipose tissue in GH receptor and prolactin receptor gene disrupted mice: Site-specific effects upon proliferation, differentiation and hormone sensitivity. The Journal of Endocrinology, 191(1), 101–111.

    Article  PubMed  CAS  Google Scholar 

  • Florini, J. R., Ewton, D. Z., & Coolican, S. A. (1996). Growth hormone and the insulin-like growth factor system in myogenesis. Endocrine Reviews, 17(5), 481–517.

    PubMed  CAS  Google Scholar 

  • Flurkey, K., Papaconstantinou, J., Miller, R. A., & Harrison, D. E. (2001). Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production. Proceedings of the National Academy of Sciences of the United States of America, 98(12), 6736–6741.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Franco, C., Brandberg, J., Lonn, L., Andersson, B., Bengtsson, B. A., & Johannsson, G. (2005). Growth hormone treatment reduces abdominal visceral fat in postmenopausal women with abdominal obesity: A 12-month placebo-controlled trial. The Journal of Clinical Endocrinology and Metabolism, 90(3), 1466–1474.

    Article  PubMed  CAS  Google Scholar 

  • Freda, P. U., Shen, W., Heymsfield, S. B., Reyes-Vidal, C. M., Geer, E. B., Bruce, J. N., & Gallagher, D. (2008). Lower Visceral and Subcutaneous but Higher Intermuscular Adipose Tissue Depots in Patients with Growth Hormone and Insulin-Like Growth Factor I Excess Due to Acromegaly. The Journal of Clinical Endocrinology and Metabolism, 93(6), 2334–2343. http://doi.org/10.1210/jc.2007-2780.

    Article  CAS  Google Scholar 

  • Ghanaat, F., & Tayek, J. A. (2005). Growth hormone administration increases glucose production by preventing the expected decrease in glycogenolysis seen with fasting in healthy volunteers. Metabolism, 54(5), 604–609. https://doi.org/10.1016/j.metabol.2004.12.003.

    Article  PubMed  CAS  Google Scholar 

  • Gibney, J., Wolthers, T., Burt, M. G., Leung, K. C., Umpleby, A. M., & Ho, K. K. (2007). Protein metabolism in acromegaly: Differential effects of short- and long-term treatment. The Journal of Clinical Endocrinology and Metabolism, 92(4), 1479–1484. https://doi.org/10.1210/jc.2006-0664.

    Article  PubMed  CAS  Google Scholar 

  • Grimberg, A., DiVall, S. A., Polychronakos, C., Allen, D. B., Cohen, L. E., Quintos, J. B., Rossi, W. C., Feudtner, C., & Murad, M. H. (2016). Guidelines for growth hormone and insulin-like growth factor-I treatment in children and adolescents: Growth hormone deficiency, idiopathic short stature, and primary insulin-like growth factor-I deficiency. Hormone Research in Pædiatrics, 86(6), 361–397. https://doi.org/10.1159/000452150.

    Article  PubMed  CAS  Google Scholar 

  • Guevara-Aguirre, J., Balasubramanian, P., Guevara-Aguirre, M., Wei, M., Madia, F., Cheng, C. W., Hwang, D., Martin-Montalvo, A., Saavedra, J., Ingles, S., de Cabo, R., Cohen, P., & Longo, V. D. (2011). Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans. Science Translational Medicine, 3(70), 70ra13.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Guevara-Aguirre, J., Rosenbloom, A. L., Balasubramanian, P., Teran, E., Guevara-Aguirre, M., Guevara, C., Procel, P., Alfaras, I., De Cabo, R., Di Biase, S., Narvaez, L., Saavedra, J., & Longo, V. D. (2015). GH receptor deficiency in Ecuadorian adults is associated with obesity and enhanced insulin sensitivity. The Journal of Clinical Endocrinology and Metabolism, 100(7), 2589–2596. https://doi.org/10.1210/jc.2015-1678.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Heiman, M. L., Tinsley, F. C., Mattison, J. A., Hauck, S., & Bartke, A. (2003). Body composition of prolactin-, growth hormone, and thyrotropin-deficient Ames dwarf mice. Endocrine, 20(1–2), 149–154.

    Article  PubMed  CAS  Google Scholar 

  • Herrington, J., Smit, L. S., Schwartz, J., & Carter-Su, C. (2000). The role of STAT proteins in growth hormone signaling. Oncogene, 19(21), 2585–2597. https://doi.org/10.1038/sj.onc.1203526.

    Article  PubMed  CAS  Google Scholar 

  • Hill, C. M., Fang, Y., Miquet, J. G., Sun, L. Y., Masternak, M. M., & Bartke, A. (2016). Long-lived hypopituitary Ames dwarf mice are resistant to the detrimental effects of high-fat diet on metabolic function and energy expenditure. Aging Cell, 15(3), 509–521. https://doi.org/10.1111/acel.12467.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Hjortebjerg, R., Berryman, D., Comisford, R., Frank, S., List, E., Bjerre, M., Frystyk, J., & Kopchick, J. (2017). Insulin, IGF-1, and GH receptors are altered in an adipose tissue depot-specific manner in male mice with modified GH action. Endocrinology, 158, 1406.

    Article  PubMed  PubMed Central  Google Scholar 

  • Hoybye, C., Chandramouli, V., Efendic, S., Hulting, A. L., Landau, B. R., Schumann, W. C., & Wajngot, A. (2008). Contribution of gluconeogenesis and glycogenolysis to hepatic glucose production in acromegaly before and after pituitary microsurgery. Hormone and Metabolic Research = Hormon- und Stoffwechselforschung = Hormones et Metabolisme, 40(7), 498–501. https://doi.org/10.1055/s-2008-1065322.

    Article  PubMed  CAS  Google Scholar 

  • Ikeno, Y., Hubbard, G. B., Lee, S., Cortez, L. A., Lew, C. M., Webb, C. R., Berryman, D. E., List, E. O., Kopchick, J. J., & Bartke, A. (2009). Reduced incidence and delayed occurrence of fatal neoplastic diseases in growth hormone receptor/binding protein knockout mice. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 64(5), 522–529.

    Article  PubMed  CAS  Google Scholar 

  • Ikkos, D., Luft, R., & Gemzell, C. A. (1959). The effect of human growth hormone in man. Acta Endocrinologica, 32, 341–361.

    Article  PubMed  CAS  Google Scholar 

  • Jenkins, P. J. (2006). Cancers associated with acromegaly. Neuroendocrinology, 83(3–4), 218–223. https://doi.org/10.1159/000095531.

    Article  PubMed  CAS  Google Scholar 

  • Johannsson, G., Marin, P., Lonn, L., Ottosson, M., Stenlof, K., Bjorntorp, P., Sjostrom, L., & Bengtsson, B. A. (1997). Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure. The Journal of Clinical Endocrinology and Metabolism, 82(3), 727–734.

    PubMed  CAS  Google Scholar 

  • Jorgensen, J. O., Moller, N., Lauritzen, T., Alberti, K. G., Orskov, H., & Christiansen, J. S. (1990). Evening versus morning injections of growth hormone (GH) in GH-deficient patients: Effects on 24-hour patterns of circulating hormones and metabolites. The Journal of Clinical Endocrinology and Metabolism, 70(1), 207–214. https://doi.org/10.1210/jcem-70-1-207.

    Article  PubMed  CAS  Google Scholar 

  • Junnila, R. K., Duran-Ortiz, S., Suer, O., Sustarsic, E. G., Berryman, D. E., List, E. O., & Kopchick, J. J. (2016). Disruption of the GH receptor gene in adult mice increases maximal lifespan in females. Endocrinology, 157(12), 4502–4513. https://doi.org/10.1210/en.2016-1649.

    Article  PubMed  CAS  Google Scholar 

  • Junnila, R. K., List, E. O., Berryman, D. E., Murrey, J. W., & Kopchick, J. J. (2013). The GH/IGF-1 axis in ageing and longevity. Nature Reviews. Endocrinology, 9(6), 366–376. https://doi.org/10.1038/nrendo.2013.67. nrendo.2013.67 [pii].

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Karastergiou, K., Bredella, M. A., Lee, M. J., Smith, S. R., Fried, S. K., & Miller, K. K. (2016). Growth hormone receptor expression in human gluteal versus abdominal subcutaneous adipose tissue: Association with body shape. Obesity, 24(5), 1090–1096. https://doi.org/10.1002/oby.21460.

    Article  PubMed  CAS  Google Scholar 

  • Katznelson, L., Atkinson, J. L., Cook, D. M., Ezzat, S. Z., Hamrahian, A. H., & Miller, K. K. (2011). American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for the diagnosis and treatment of acromegaly--2011 update: Executive summary. Endocrine Practice, 17(4), 636–646.

    Article  PubMed  Google Scholar 

  • Katznelson, L., Laws, E. R., Jr., Melmed, S., Molitch, M. E., Murad, M. H., Utz, A., & Wass, J. A. (2014). Acromegaly: An endocrine society clinical practice guideline. The Journal of Clinical Endocrinology and Metabolism, 99(11), 3933–3951. https://doi.org/10.1210/jc.2014-2700.

    Article  PubMed  CAS  Google Scholar 

  • Kelder, B., Berryman, D. E., Clark, R., Li, A., List, E. O., & Kopchick, J. J. (2007). CIDE-A gene expression is decreased in white adipose tissue of growth hormone receptor/binding protein gene disrupted mice and with high-fat feeding of normal mice. Growth Hormone & IGF Research, 17(4), 346–351.

    Article  CAS  Google Scholar 

  • Khalfallah, Y., Sassolas, G., Borson-Chazot, F., Vega, N., & Vidal, H. (2001). Expression of insulin target genes in skeletal muscle and adipose tissue in adult patients with growth hormone deficiency: Effect of one year recombinant human growth hormone therapy. The Journal of Endocrinology, 171(2), 285–292.

    Article  PubMed  CAS  Google Scholar 

  • Kim, D. S., Itoh, E., Iida, K., & Thorner, M. O. (2009). Growth hormone increases mRNA levels of PPARdelta and Foxo1 in skeletal muscle of growth hormone deficient lit/lit mice. Endocrine Journal, 56(1), 141–147.

    Article  PubMed  CAS  Google Scholar 

  • Kim, K. R., Nam, S. Y., Song, Y. D., Lim, S. K., Lee, H. C., & Huh, K. B. (1999). Low-dose growth hormone treatment with diet restriction accelerates body fat loss, exerts anabolic effect and improves growth hormone secretory dysfunction in obese adults. Hormone Research, 51(2), 78–84.

    Article  PubMed  CAS  Google Scholar 

  • Kopchick, J. J., & Andry, J. M. (2000). Growth hormone (GH), GH receptor, and signal transduction. Molecular Genetics and Metabolism, 71(1–2), 293–314.

    Article  PubMed  CAS  Google Scholar 

  • Kopchick, J. J., & Laron, Z. (1999). Is the Laron mouse an accurate model of Laron syndrome? Molecular Genetics and Metabolism, 68, 232–236.

    Article  PubMed  CAS  Google Scholar 

  • Kopchick, J. J., & Laron, Z. (Eds.). (2011). Laron syndrome - from man to mouse. Berlin: Springer.

    Google Scholar 

  • Kopchick, J. J., List, E. O., Kelder, B., Gosney, E. S., & Berryman, D. E. (2014). Evaluation of growth hormone (GH) action in mice: Discovery of GH receptor antagonists and clinical indications. Molecular and Cellular Endocrinology, 386(1–2), 34–45. https://doi.org/10.1016/j.mce.2013.09.004. S0303-7207(13)00366-3 [pii].

    Article  PubMed  CAS  Google Scholar 

  • Kredel, L. I., & Siegmund, B. (2014). Adipose-tissue and intestinal inflammation - visceral obesity and creeping fat. Frontiers in Immunology, 5, 462. https://doi.org/10.3389/fimmu.2014.00462.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Lam, K. S., Xu, A., Tan, K. C., Wong, L. C., Tiu, S. C., & Tam, S. (2004). Serum adiponectin is reduced in acromegaly and normalized after correction of growth hormone excess. The Journal of Clinical Endocrinology and Metabolism, 89(11), 5448–5453.

    Article  PubMed  CAS  Google Scholar 

  • Laron, Z. (2015). Lessons from 50 years of study of Laron syndrome. Endocrine Practice, 21(12), 1395–1402. https://doi.org/10.4158/EP15939.RA.

    Article  PubMed  Google Scholar 

  • Laron, Z., Ginsberg, S., Lilos, P., Arbiv, M., & Vaisman, N. (2006). Body composition in untreated adult patients with Laron syndrome (primary GH insensitivity). Clinical Endocrinology, 65(1), 114–117. doi:CEN2558 [pii]. https://doi.org/10.1111/j.1365-2265.2006.02558.x.

    Article  PubMed  CAS  Google Scholar 

  • Laron, Z., & Kauli, R. (2016). Fifty seven years of follow-up of the Israeli cohort of Laron syndrome patients-from discovery to treatment. Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society, 28, 53–56. https://doi.org/10.1016/j.ghir.2015.08.004.

    Article  Google Scholar 

  • Laron, Z., Pertzelan, A., & Karp, M. (1968). Pituitary dwarfism with high serum levels of growth hormone. Israel Journal of Medical Sciences, 4(4), 883–894.

    PubMed  CAS  Google Scholar 

  • Li, Y., Knapp, J. R., & Kopchick, J. J. (2003). Enlargement of interscapular brown adipose tissue in growth hormone antagonist transgenic and in growth hormone receptor gene-disrupted dwarf mice. Experimental Biology and Medicine (Maywood, N.J.), 228(2), 207–215.

    Article  CAS  Google Scholar 

  • Lindberg-Larsen, R., Moller, N., Schmitz, O., Nielsen, S., Andersen, M., Orskov, H., & Jorgensen, J. O. (2007). The impact of pegvisomant treatment on substrate metabolism and insulin sensitivity in patients with acromegaly. The Journal of Clinical Endocrinology and Metabolism, 92(5), 1724–1728.

    Article  PubMed  CAS  Google Scholar 

  • List, E. O., Berryman, D. E., Funk, K., Gosney, E. S., Jara, A., Kelder, B., Wang, X., Kutz, L., Troike, K., Lozier, N., Mikula, V., Lubbers, E. R., Zhang, H., Vesel, C., Junnila, R. K., Frank, S. J., Masternak, M. M., Bartke, A., & Kopchick, J. J. (2013). The role of GH in adipose tissue: Lessons from adipose-specific GH receptor gene-disrupted mice. Molecular Endocrinology, 27(3), 524–535. https://doi.org/10.1210/me.2012-1330. me.2012-1330 [pii].

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • List, E. O., Berryman, D. E., Funk, K., Jara, A., Kelder, B., Wang, F., Stout, M. B., Zhi, X., Sun, L., White, T. A., LeBrasseur, N. K., Pirtskhalava, T., Tchkonia, T., Jensen, E. A., Zhang, W., Masternak, M. M., Kirkland, J. L., Miller, R. A., Bartke, A., & Kopchick, J. J. (2014). Liver-specific GH receptor gene-disrupted (LiGHRKO) mice have decreased endocrine IGF-I, increased local IGF-I, and altered body size, body composition, and adipokine profiles. Endocrinology, 155(5), 1793–1805. https://doi.org/10.1210/en.2013-2086.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • List, E. O., Berryman, D. E., Ikeno, Y., Hubbard, G. B., Funk, K., Comisford, R., Young, J. A., Stout, M. B., Tchkonia, T., Masternak, M. M., Bartke, A., Kirkland, J. L., Miller, R. A., & Kopchick, J. J. (2015). Removal of growth hormone receptor (GHR) in muscle of male mice replicates some of the health benefits seen in global GHR−/− mice. Aging (Albany NY), 7(7), 500–512.

    Article  CAS  Google Scholar 

  • List, E. O., Palmer, A. J., Berryman, D. E., Bower, B., Kelder, B., & Kopchick, J. J. (2009). Growth hormone improves body composition, fasting blood glucose, glucose tolerance and liver triacylglycerol in a mouse model of diet-induced obesity and type 2 diabetes. Diabetologia, 52(8), 1647–1655.

    Article  PubMed  CAS  Google Scholar 

  • Lu, C., Kumar, P. A., Sun, J., Aggarwal, A., Fan, Y., Sperling, M. A., Lumeng, C. N., & Menon, R. K. (2013). Targeted deletion of growth hormone (GH) receptor in macrophage reveals novel Osteopontin-mediated effects of GH on glucose homeostasis and insulin sensitivity in diet-induced obesity. The Journal of Biological Chemistry, 288(22), 15725–15735. https://doi.org/10.1074/jbc.M113.460212. M113.460212 [pii].

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Lubbers, E. R., List, E. O., Jara, A., Sackmann-Sala, L., Cordoba-Chacon, J., Gahete, M., Kineman, R. D., Boparai, R., Bartke, A., Kopchick, J., & Berryman, D. E. (2012). Adiponectin in mice with altered growth hormone action: Links to insulin sensitivity and longevity? The Journal of Endocrinology. https://doi.org/10.1530/JOE-12-0505.

  • Lubbers, E. R., List, E. O., Jara, A., Sackman-Sala, L., Cordoba-Chacon, J., Gahete, M. D., Kineman, R. D., Boparai, R., Bartke, A., Kopchick, J. J., & Berryman, D. E. (2013). Adiponectin in mice with altered GH action: Links to insulin sensitivity and longevity? The Journal of Endocrinology, 216(3), 363–374. https://doi.org/10.1530/JOE-12-0505. JOE-12-0505 [pii].

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Luque, R. M., Lin, Q., Cordoba-Chacon, J., Subbaiah, P. V., Buch, T., Waisman, A., Vankelecom, H., & Kineman, R. D. (2011). Metabolic impact of adult-onset, isolated, growth hormone deficiency (AOiGHD) due to destruction of pituitary Somatotropes. PLoS One, 6(1), e15767.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Masternak, M. M., Al-Regaiey, K. A., Del Rosario Lim, M. M., Jimenez-Ortega, V., Panici, J. A., Bonkowski, M. S., Kopchick, J. J., Wang, Z., & Bartke, A. (2006). Caloric restriction and growth hormone receptor knockout: Effects on expression of genes involved in insulin action in the heart. Experimental Gerontology, 41(4), 417–429.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Mavalli, M. D., DiGirolamo, D. J., Fan, Y., Riddle, R. C., Campbell, K. S., van Groen, T., Frank, S. J., Sperling, M. A., Esser, K. A., Bamman, M. M., & Clemens, T. L. (2010). Distinct growth hormone receptor signaling modes regulate skeletal muscle development and insulin sensitivity in mice. The Journal of Clinical Investigation, 120(11), 4007–4020.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Meazza, C., Elsedfy, H. H., Pagani, S., Bozzola, E., El Kholy, M., & Bozzola, M. (2014). Metabolic parameters and adipokine profile in growth hormone deficient (GHD) children before and after 12-month GH treatment. Hormone and Metabolic Research = Hormon- und Stoffwechselforschung = Hormones et Metabolisme, 46(3), 219–223. https://doi.org/10.1055/s-0033-1358730.

    Article  PubMed  CAS  Google Scholar 

  • Mekala, K. C., & Tritos, N. A. (2008). Effects of recombinant human growth hormone therapy in obesity in adults - a meta-analysis. The Journal of Clinical Endocrinology and Metabolism.

    Google Scholar 

  • Melmed, S. (2009). Acromegaly pathogenesis and treatment. The Journal of Clinical Investigation, 119(11), 3189–3202. https://doi.org/10.1172/JCI39375.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Melmed, S. (2011). Pathogenesis of pituitary tumors. Nature Reviews Endocrinology, 7(5), 257–266. https://doi.org/10.1038/nrendo.2011.40.

    Article  PubMed  CAS  Google Scholar 

  • Melmed, S., Kleinberg, D. L., Bonert, V., & Fleseriu, M. (2014). Acromegaly: Assessing the disorder and navigating therapeutic options for treatment. Endocrine Practice, 20(Suppl 1), 7–17. quiz 18–20. https://doi.org/10.4158/EP14430.RA.

    Article  PubMed  Google Scholar 

  • Miquet, J. G., Freund, T., Martinez, C. S., Gonzalez, L., Diaz, M. E., Micucci, G. P., Zotta, E., Boparai, R. K., Bartke, A., Turyn, D., & Sotelo, A. I. (2013). Hepatocellular alterations and dysregulation of oncogenic pathways in the liver of transgenic mice overexpressing growth hormone. Cell Cycle, 12(7), 1042–1057. https://doi.org/10.4161/cc.24026. 24026 [pii].

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Molitch, M. E., Clemmons, D. R., Malozowski, S., Merriam, G. R., & Vance, M. L. (2011). Evaluation and treatment of adult growth hormone deficiency: An Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology and Metabolism, 96(6), 1587–1609. https://doi.org/10.1210/jc.2011-0179.

    Article  PubMed  CAS  Google Scholar 

  • Moller, N., & Jorgensen, J. O. (2009). Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocrine Reviews, 30(2), 152–177.

    Article  PubMed  CAS  Google Scholar 

  • Moller, N., Vendelbo, M. H., Kampmann, U., Christensen, B., Madsen, M., Norrelund, H., & Jorgensen, J. O. (2009). Growth hormone and protein metabolism. Clinical Nutrition, 28(6), 597–603. https://doi.org/10.1016/j.clnu.2009.08.015S0261-5614(09)00177-0. [pii].

    Article  PubMed  CAS  Google Scholar 

  • Muller, E. E. (1990). Clinical implications of growth hormone feedback mechanisms. Hormone Research, 33(Suppl 4), 90–96.

    PubMed  Google Scholar 

  • Muller, E. E., Locatelli, V., & Cocchi, D. (1999). Neuroendocrine control of growth hormone secretion. Physiological Reviews, 79(2), 511–607.

    Article  PubMed  CAS  Google Scholar 

  • Mulligan, K., Tai, V. W., & Schambelan, M. (1998). Effects of chronic growth hormone treatment on energy intake and resting energy metabolism in patients with human immunodeficiency virus-associated wasting--a clinical research center study. The Journal of Clinical Endocrinology and Metabolism, 83(5), 1542–1547. https://doi.org/10.1210/jcem.83.5.4772.

    Article  PubMed  CAS  Google Scholar 

  • Mullis, P. E. (2007). Genetics of growth hormone deficiency. Endocrinology and Metabolism Clinics of North America, 36(1), 17–36. https://doi.org/10.1016/j.ecl.2006.11.010.

    Article  PubMed  CAS  Google Scholar 

  • Murase, T., Yamada, N., Ohsawa, N., Kosaka, K., Morita, S., & Yoshida, S. (1980). Decline of postheparin plasma lipoprotein lipase in acromegalic patients. Metabolism, 29(7), 666–672.

    Article  PubMed  CAS  Google Scholar 

  • Nam, S. Y., Kim, K. R., Cha, B. S., Song, Y. D., Lim, S. K., Lee, H. C., & Huh, K. B. (2001). Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients. International Journal of Obesity and Related Metabolic Disorders, 25(8), 1101–1107.

    Article  PubMed  CAS  Google Scholar 

  • Nishizawa, H., Iguchi, G., Murawaki, A., Fukuoka, H., Hayashi, Y., Kaji, H., Yamamoto, M., Suda, K., Takahashi, M., Seo, Y., Yano, Y., Kitazawa, R., Kitazawa, S., Koga, M., Okimura, Y., Chihara, K., & Takahashi, Y. (2012). Nonalcoholic fatty liver disease in adult hypopituitary patients with GH deficiency and the impact of GH replacement therapy. European Journal of Endocrinology, 167(1), 67–74. https://doi.org/10.1530/EJE-12-0252.

    Article  PubMed  CAS  Google Scholar 

  • Olarescu, N. C., Berryman, D. E., Householder, L. A., Lubbers, E. R., List, E. O., Benencia, F., Kopchick, J. J., & Bollerslev, J. (2015a). GH action influences adipogenesis of mouse adipose tissue-derived mesenchymal stem cells. The Journal of Endocrinology, 226(1), 13–23. https://doi.org/10.1530/JOE-15-0012.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Olarescu, N. C., Heck, A., Godang, K., Ueland, T., & Bollerslev, J. (2015b). The metabolic risk in newly diagnosed patients with acromegaly is related to fat distribution and circulating Adipokines and improves after treatment. Neuroendocrinology. https://doi.org/10.1159/000371818.

  • Olsson, B., Bohlooly, Y. M., Fitzgerald, S. M., Frick, F., Ljungberg, A., Ahren, B., Tornell, J., Bergstrom, G., & Oscarsson, J. (2005). Bovine growth hormone transgenic mice are resistant to diet-induced obesity but develop hyperphagia, dyslipidemia, and diabetes on a high-fat diet. Endocrinology, 146(2), 920–930.

    Article  PubMed  CAS  Google Scholar 

  • Oscarsson, J., Ottosson, M., Vikman-Adolfsson, K., Frick, F., Enerback, S., Lithell, H., & Eden, S. (1999). GH but not IGF-I or insulin increases lipoprotein lipase activity in muscle tissues of hypophysectomised rats. The Journal of Endocrinology, 160(2), 247–255.

    Article  PubMed  CAS  Google Scholar 

  • Palmer, A. J., Chung, M. Y., List, E. O., Walker, J., Okada, S., Kopchick, J. J., & Berryman, D. E. (2009). Age-related changes in body composition of bovine growth hormone transgenic mice. Endocrinology, 150(3), 1353–1360.

    Article  PubMed  CAS  Google Scholar 

  • Raben, M. S., & Hollenberg, C. H. (1959). Effect of growth hormone on plasma fatty acids. The Journal of Clinical Investigation, 38(3), 484–488. https://doi.org/10.1172/JCI103824.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Rabinowitz, D., Klassen, G. A., & Zierler, K. L. (1965). Effect of human growth hormone on muscle and adipose tissue metabolism in the forearm of man. The Journal of Clinical Investigation, 44, 51–61.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Rabinowitz, D., & Zierler, K. L. (1963). A metabolic regulating device based on the actions of human growth hormone and of insulin, singly and together, on the human forearm. Nature, 199, 913–915.

    Article  PubMed  CAS  Google Scholar 

  • Rasmussen, M. H. (2010). Obesity, growth hormone and weight loss. Molecular and Cellular Endocrinology, 316(2), 147–153. https://doi.org/10.1016/j.mce.2009.08.017.

    Article  PubMed  CAS  Google Scholar 

  • Rasmussen, M. H., Hvidberg, A., Juul, A., Main, K. M., Gotfredsen, A., Skakkebaek, N. E., Hilsted, J., & Skakkebae, N. E. (1995). Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects. The Journal of Clinical Endocrinology and Metabolism, 80(4), 1407–1415. https://doi.org/10.1210/jcem.80.4.7536210.

    Article  PubMed  CAS  Google Scholar 

  • Reed, M. L., Merriam, G. R., & Kargi, A. Y. (2013). Adult growth hormone deficiency - benefits, side effects, and risks of growth hormone replacement. Front Endocrinol (Lausanne), 4, 64. https://doi.org/10.3389/fendo.2013.00064.

    Article  Google Scholar 

  • Reyes-Vidal, C., Fernandez, J. C., Bruce, J. N., Crisman, C., Conwell, I. M., Kostadinov, J., Geer, E. B., Post, K. D., & Freda, P. U. (2014). Prospective study of surgical treatment of acromegaly: Effects on ghrelin, weight, adiposity, and markers of CV risk. The Journal of Clinical Endocrinology and Metabolism, 99(11), 4124–4132. https://doi.org/10.1210/jc.2014-2259.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Richelsen, B., Pedersen, S. B., Borglum, J. D., Moller-Pedersen, T., Jorgensen, J., & Jorgensen, J. O. (1994). Growth hormone treatment of obese women for 5 wk: Effect on body composition and adipose tissue LPL activity. The American Journal of Physiology, 266(2 Pt 1), E211–E216.

    PubMed  CAS  Google Scholar 

  • Richelsen, B., Pedersen, S. B., Kristensen, K., Borglum, J. D., Norrelund, H., Christiansen, J. S., & Jorgensen, J. O. (2000). Regulation of lipoprotein lipase and hormone-sensitive lipase activity and gene expression in adipose and muscle tissue by growth hormone treatment during weight loss in obese patients. Metabolism, 49(7), 906–911.

    Article  PubMed  CAS  Google Scholar 

  • Robertson, K., Kopchick, J. J., & Liu, J. L. (2006). Growth hormone receptor gene deficiency causes delayed insulin responsiveness in skeletal muscles without affecting compensatory islet cell overgrowth in obese mice. American Journal of Physiology. Endocrinology and Metabolism, 291(3), E491–E498.

    Article  PubMed  CAS  Google Scholar 

  • Rodriguez-Arnao, J., Jabbar, A., Fulcher, K., Besser, G. M., & Ross, R. J. (1999). Effects of growth hormone replacement on physical performance and body composition in GH deficient adults. Clinical Endocrinology, 51(1), 53–60.

    Article  PubMed  CAS  Google Scholar 

  • Rogozinski, A., Furioso, A., Glikman, P., Junco, M., Laudi, R., Reyes, A., & Lowenstein, A. (2012). Thyroid nodules in acromegaly. Arquivos Brasileiros de Endocrinologia e Metabologia, 56(5), 300–304.

    Article  PubMed  Google Scholar 

  • Rokkas, T., Pistiolas, D., Sechopoulos, P., Margantinis, G., & Koukoulis, G. (2008). Risk of colorectal neoplasm in patients with acromegaly: A meta-analysis. World Journal of Gastroenterology, 14(22), 3484–3489.

    Article  PubMed  PubMed Central  Google Scholar 

  • Romero, C. J., Ng, Y., Luque, R. M., Kineman, R. D., Koch, L., Bruning, J. C., & Radovick, S. (2010). Targeted deletion of somatotroph insulin-like growth factor-I signaling in a cell-specific knockout mouse model. Molecular Endocrinology, 24(5), 1077–1089. https://doi.org/10.1210/me.2009-0393.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Sackmann-Sala, L., Berryman, D. E., Lubbers, E. R., Zhang, H., Vesel, C. B., Troike, K. M., Gosney, E. S., List, E. O., & Kopchick, J. J. (2013). Age-related and depot-specific changes in white adipose tissue of growth hormone receptor-null mice. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences. https://doi.org/10.1093/gerona/glt110.

    Article  CAS  Google Scholar 

  • Sakharova, A. A., Horowitz, J. F., Surya, S., Goldenberg, N., Harber, M. P., Symons, K., & Barkan, A. (2008). Role of growth hormone in regulating lipolysis, proteolysis, and hepatic glucose production during fasting. The Journal of Clinical Endocrinology and Metabolism, 93(7), 2755–2759. doi:jc.2008-0079. [pii]. https://doi.org/10.1210/jc.2008-0079.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Shadid, S., & Jensen, M. D. (2003). Effects of growth hormone administration in human obesity. Obesity Research, 11(2), 170–175.

    Article  PubMed  CAS  Google Scholar 

  • Shevah, O., & Laron, Z. (2007). Patients with congenital deficiency of IGF-I seem protected from the development of malignancies: A preliminary report. Growth Hormone & IGF Research, 17(1), 54–57.

    Article  CAS  Google Scholar 

  • Shin-Hye Kim, Mi-Jung Park, (2017) Effects of growth hormone on glucose metabolism and insulin resistance in human. Annals of Pediatric Endocrinology & Metabolism 22(3):145–152.

    Article  Google Scholar 

  • Silha, J. V., Krsek, M., Hana, V., Marek, J., Jezkova, J., Weiss, V., & Murphy, L. J. (2003). Perturbations in adiponectin, leptin and resistin levels in acromegaly: Lack of correlation with insulin resistance. Clinical Endocrinology, 58(6), 736–742.

    Article  PubMed  CAS  Google Scholar 

  • Skaggs, S. R., & Crist, D. M. (1991). Exogenous human growth hormone reduces body fat in obese women. Hormone Research, 35(1), 19–24.

    Article  PubMed  CAS  Google Scholar 

  • Smuel, K., Kauli, R., Lilos, P., & Laron, Z. (2015). Growth, development, puberty and adult height before and during treatment in children with congenital isolated growth hormone deficiency. Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society, 25(4), 182–188. https://doi.org/10.1016/j.ghir.2015.05.001.

    Article  CAS  Google Scholar 

  • Snyder, D. K., Clemmons, D. R., & Underwood, L. E. (1988). Treatment of obese, diet-restricted subjects with growth hormone for 11 weeks: Effects on anabolism, lipolysis, and body composition. The Journal of Clinical Endocrinology and Metabolism, 67(1), 54–61.

    Article  PubMed  CAS  Google Scholar 

  • Snyder, D. K., Underwood, L. E., & Clemmons, D. R. (1990). Anabolic effects of growth hormone in obese diet-restricted subjects are dose dependent. The American Journal of Clinical Nutrition, 52(3), 431–437.

    Article  PubMed  CAS  Google Scholar 

  • Snyder, D. K., Underwood, L. E., & Clemmons, D. R. (1995). Persistent lipolytic effect of exogenous growth hormone during caloric restriction. The American Journal of Medicine, 98(2), 129–134.

    Article  PubMed  CAS  Google Scholar 

  • Sornson, M. W., Wu, W., Dasen, J. S., Flynn, S. E., Norman, D. J., O’Connell, S. M., Gukovsky, I., Carriere, C., Ryan, A. K., Miller, A. P., Zuo, L., Gleiberman, A. S., Andersen, B., Beamer, W. G., & Rosenfeld, M. G. (1996). Pituitary lineage determination by the prophet of Pit-1 homeodomain factor defective in Ames dwarfism. Nature, 384(6607), 327–333. https://doi.org/10.1038/384327a0.

    Article  PubMed  CAS  Google Scholar 

  • Stenholm, S., Metter, E. J., Roth, G. S., Ingram, D. K., Mattison, J. A., Taub, D. D., & Ferrucci, L. (2011). Relationship between plasma ghrelin, insulin, leptin, interleukin 6, adiponectin, testosterone and longevity in the Baltimore longitudinal study of aging. Aging Clinical and Experimental Research, 23(2), 153–158.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Steuerman, R., Shevah, O., & Laron, Z. (2011). Congenital IGF1 deficiency tends to confer protection against post-natal development of malignancies. European Journal of Endocrinology, 164(4), 485–489. https://doi.org/10.1530/EJE-10-0859.

    Article  PubMed  CAS  Google Scholar 

  • Stout, M. B., Swindell, W. R., Zhi, X., Rohde, K., List, E. O., Berryman, D. E., Kopchick, J. J., Gesing, A., Fang, Y., & Masternak, M. M. (2015). Transcriptome profiling reveals divergent expression shifts in brown and white adipose tissue from long-lived GHRKO mice. Oncotarget, 6(29), 26702–26715. https://doi.org/10.18632/oncotarget.5760.

    Article  PubMed  PubMed Central  Google Scholar 

  • Stout, M. B., Tchkonia, T., Pirtskhalava, T., Palmer, A. K., List, E. O., Berryman, D. E., Lubbers, E. R., Escande, C., Spong, A., Masternak, M. M., Oberg, A. L., LeBrasseur, N. K., Miller, R. A., Kopchick, J. J., Bartke, A., & Kirkland, J. L. (2014). Growth hormone action predicts age-related white adipose tissue dysfunction and senescent cell burden in mice. Aging (Albany NY), 6(7), 575–586.

    Article  Google Scholar 

  • Sucunza, N., Barahona, M. J., Resmini, E., Fernandez-Real, J. M., Ricart, W., Farrerons, J., Rodriguez Espinosa, J., Marin, A. M., Puig, T., & Webb, S. M. (2009). A link between bone mineral density and serum adiponectin and visfatin levels in acromegaly. The Journal of Clinical Endocrinology and Metabolism, 94(10), 3889–3896.

    Article  PubMed  CAS  Google Scholar 

  • Tagliaferri, M., Scacchi, M., Pincelli, A. I., Berselli, M. E., Silvestri, P., Montesano, A., Ortolani, S., Dubini, A., & Cavagnini, F. (1998). Metabolic effects of biosynthetic growth hormone treatment in severely energy-restricted obese women. International Journal of Obesity and Related Metabolic Disorders, 22(9), 836–841.

    Article  PubMed  CAS  Google Scholar 

  • Troike, K. M., Henry, B. E., Jensen, E. A., Young, J. A., List, E. O., Kopchick, J. J., & Berryman, D. E. (2017). Impact of Growth Hormone on Regulation of Adipose Tissue. Comprehensive Physiology, 7(3), 819–840. https://doi.org/10.1002/cphy.c160027.

  • van Vught, A. J., Nieuwenhuizen, A. G., Brummer, R. J., & Westerterp-Plantenga, M. S. (2008). Effects of oral ingestion of amino acids and proteins on the somatotropic axis. The Journal of Clinical Endocrinology and Metabolism, 93(2), 584–590. https://doi.org/10.1210/jc.2007-1784.

    Article  PubMed  CAS  Google Scholar 

  • Vikman, K., Carlsson, B., Billig, H., & Eden, S. (1991). Expression and regulation of growth hormone (GH) receptor messenger ribonucleic acid (mRNA) in rat adipose tissue, adipocytes, and adipocyte precursor cells: GH regulation of GH receptor mRNA. Endocrinology, 129(3), 1155–1161.

    Article  PubMed  CAS  Google Scholar 

  • Wang, Z., Al-Regaiey, K. A., Masternak, M. M., & Bartke, A. (2006). Adipocytokines and lipid levels in Ames dwarf and calorie-restricted mice. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 61(4), 323–331.

    Article  PubMed  Google Scholar 

  • Wang, Z., Masternak, M. M., Al-Regaiey, K. A., & Bartke, A. (2007). Adipocytokines and the regulation of lipid metabolism in growth hormone transgenic and calorie-restricted mice. Endocrinology, 148(6), 2845–2853. https://doi.org/10.1210/en.2006-1313.

    Article  PubMed  CAS  Google Scholar 

  • Wells, J. A. (1996). Binding in the growth hormone receptor complex. Proceedings of the National Academy of Sciences, 93(1), 1–6.

    Article  CAS  Google Scholar 

  • Wu, Y., Liu, C., Sun, H., Vijayakumar, A., Giglou, P. R., Qiao, R., Oppenheimer, J., Yakar, S., & LeRoith, D. (2011). Growth hormone receptor regulates beta cell hyperplasia and glucose-stimulated insulin secretion in obese mice. The Journal of Clinical Investigation, 121(6), 2422–2426. https://doi.org/10.1172/JCI45027.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Yakar, S., Setser, J., Zhao, H., Stannard, B., Haluzik, M., Glatt, V., Bouxsein, M. L., Kopchick, J. J., & LeRoith, D. (2004). Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1-deficient mice. The Journal of Clinical Investigation, 113(1), 96–105.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Yang, S., Mulder, H., Holm, C., & Eden, S. (2004). Effects of growth hormone on the function of beta-adrenoceptor subtypes in rat adipocytes. Obesity Research, 12(2), 330–339. https://doi.org/10.1038/oby.2004.41.

    Article  PubMed  CAS  Google Scholar 

  • Yang, T., Householder, L. A., Lubbers, E. R., List, E. O., Troike, K., Vesel, C., Duran-Ortiz, S., Kopchick, J. J., & Berryman, D. E. (2015). Growth hormone receptor antagonist transgenic mice are protected from hyperinsulinemia and glucose intolerance despite obesity when placed on a HF diet. Endocrinology, 156(2), 555–564. https://doi.org/10.1210/en.2014-1617.

    Article  PubMed  CAS  Google Scholar 

  • Yip, R. G., & Goodman, H. M. (1999). Growth hormone and dexamethasone stimulate lipolysis and activate adenylyl cyclase in rat adipocytes by selectively shifting Gi alpha2 to lower density membrane fractions. Endocrinology, 140(3), 1219–1227. https://doi.org/10.1210/endo.140.3.6580.

    Article  PubMed  CAS  Google Scholar 

  • Zhang, Q., Kohler, M., Yang, S. N., Zhang, F., Larsson, O., & Berggren, P. O. (2004). Growth hormone promotes ca(2+)-induced Ca2+ release in insulin-secreting cells by ryanodine receptor tyrosine phosphorylation. Molecular Endocrinology, 18(7), 1658–1669. https://doi.org/10.1210/me.2004-0044.

    Article  PubMed  CAS  Google Scholar 

  • Zhou, Y., Xu, B. C., Maheshwari, H. G., He, L., Reed, M., Lozykowski, M., Okada, S., Cataldo, L., Coschigamo, K., Wagner, T. E., Baumann, G., & Kopchick, J. J. (1997). A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). Proceedings of the National Academy of Sciences of the United States of America, 94(24), 13215–13220.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Zou, L., Menon, R. K., & Sperling, M. A. (1997). Induction of mRNAs for the growth hormone receptor gene during mouse 3T3-L1 preadipocyte differentiation. Metabolism, 46(1), 114–118.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Darlene E. Berryman .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Henry, B., Jensen, E.A., List, E.O., Berryman, D.E. (2018). Obesity and the Growth Hormone Axis. In: Nillni, E. (eds) Textbook of Energy Balance, Neuropeptide Hormones, and Neuroendocrine Function. Springer, Cham. https://doi.org/10.1007/978-3-319-89506-2_12

Download citation

Publish with us

Policies and ethics